Meiji Pharmaceutical University
In research, Meiji Pharmaceutical University stands highest in Life Sciences (#4,694 of 6,403 worldwide), Medicine (#6,375 of 8,541 worldwide) and Health Sciences (#7,544 of 9,902 worldwide), 2022-now. Relative to its size it is most specialised in Pharmacology, Toxicology and Pharmaceutics and Organic Chemistry (Pharmacology, Toxicology and Pharmaceutics is 17.2× its share of world research).
- World rank, 2022-now
- #14,929 of 22,385 · #11,090 all time
- Rank in Japan
- #436 of 924
- Research works
- 1.9k ▲ 4% vs 2018-21
- Citations
- 36k 19.5 per fractional work
- Top-10% rate
- 4.4% all institutions 10.0%
- vs its own fields
- 0.85× 1.00× is exactly expected
- Open access
- 52% world 40%
- International
- 8% world 18%
What is Meiji Pharmaceutical University known for in research?
The fields where it stands highest, 2022-now, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| Life SciencesDomain | #4,694 of 6,403 | 4.4% | 102 | #3984 | |
| MedicineField | #6,375 of 8,541 | 4.9% | 122 | #6496 | |
| Health SciencesDomain | #7,544 of 9,902 | 5.2% | 127 | #7157 |
Each strip is that field's whole ranked pool, with the notch where Meiji Pharmaceutical University sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).
Which of those standings moved
The same fields on both windows: where it stood over the whole record, and where it stands in 2022-now. The distance is the story, and it is the one thing the two rank columns above cannot show.
- Life Sciences#3,984 #4,694
- Medicine#6,496 #6,375
- Health Sciences#7,157 #7,544
A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.
Which fields of science does Meiji Pharmaceutical University work in?
In 2022-now, 43% of research at Meiji Pharmaceutical University is in Health Sciences, 35% in Life Sciences. Its largest fields are Medicine (41%), Biochemistry, Genetics and Molecular Biology (21%), Chemistry (11%). It does 2.6× the world's share of Life Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 24 fields, with their numbers
- Health Sciences14742.6%
- Medicine14140.9%
- Health Professions30.8%
- Nursing20.4%
- Veterinary10.3%
- Dentistry10.2%
- Life Sciences12135.0%
- Physical Sciences6217.9%
- Chemistry3710.8%
- Materials Science92.6%
- Computer Science61.6%
- Engineering41.1%
- Mathematics31.0%
- Environmental Science20.6%
- Chemical Engineering00.1%
- Energy00.1%
- Physics and Astronomy00.0%
- Social Sciences154.5%
- Economics, Econometrics and Finance102.9%
- Social Sciences20.7%
- Psychology20.6%
- Arts and Humanities00.1%
- Decision Sciences00.1%
What does Meiji Pharmaceutical University specialise in?
Where its research is concentrated relative to its size: Pharmacology, Toxicology and Pharmaceutics takes 17.2× the share of its output that it takes of world research.
- Pharmacology, Toxicology and PharmaceuticsField · 20.9 works17×
- Organic ChemistrySubfield · 29.5 works11×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 17.2×. Every wedge is a field page.
All 24 fields, with their numbers
- Pharmacology, Toxicology and Pharmaceutics17.16×21 works
- Chemistry6.90×37 works
- Biochemistry, Genetics and Molecular Biology3.89×72 works
- Immunology and Microbiology3.56×12 works
- Veterinary2.49×1 works
- Medicine2.13×141 works
- Neuroscience1.54×9 works
- Economics, Econometrics and Finance1.37×10 works
- Nursing0.91×2 works
- Mathematics0.81×3 works
- Materials Science0.75×9 works
- Agricultural and Biological Sciences0.45×8 works
- Dentistry0.37×1 works
- Health Professions0.29×3 works
- Chemical Engineering0.28×0 works
- Computer Science0.21×6 works
- Psychology0.19×2 works
- Environmental Science0.11×2 works
- Decision Sciences0.10×0 works
- Energy0.07×0 works
- Engineering0.07×4 works
- Social Sciences0.06×2 works
- Arts and Humanities0.05×0 works
- Physics and Astronomy0.02×0 works
- Pharmacology, Toxicology and Pharmaceutics 17.2×
- Chemistry 6.9×
- Biochemistry, Genetics and Molecular Biology 3.9×
- Immunology and Microbiology 3.6×
- Veterinary 2.5×
- Medicine 2.1×
- Neuroscience 1.5×
- Economics, Econometrics and Finance 1.4×
- Nursing 0.9×
- Mathematics 0.8×
- Materials Science 0.8×
- Agricultural and Biological Sciences 0.5×
- Dentistry 0.4×
- Health Professions 0.3×
- Chemical Engineering 0.3×
- Computer Science 0.2×
- Psychology 0.2×
- Environmental Science 0.1×
- Decision Sciences 0.1×
- Energy 0.1×
- Engineering 0.1×
- Social Sciences 0.1×
- Arts and Humanities 0.1×
- Physics and Astronomy 0.0×
Who are the top researchers at Meiji Pharmaceutical University?
Ranked on the quality score, Yoshihiro Kino, Satoshi Hayashi and Masahiro Noji lead among researchers whose main affiliation is Meiji Pharmaceutical University.
- 1
Yoshihiro Kino
Japan · #1,785,935 worldwide 4.1k citations · 88 works
- 2
Satoshi Hayashi
Japan · #1,924,989 worldwide 3.1k citations · 133 works
- 3
Masahiro Noji
Japan · #2,070,889 worldwide 1.2k citations · 80 works
- 4
Mizuho Asada
Japan · #2,182,720 worldwide 314 citations · 29 works
- 5
Yasuhiro Ogawa
Japan · #2,204,004 worldwide 3.1k citations · 105 works
- 6
Yoji Ikegami
Japan · #2,330,942 worldwide 2.2k citations · 48 works
- 7
Kiyoharu Kawakami
Japan · #2,548,260 worldwide 203 citations · 17 works
- 8
Masanori Tayu
Japan · #2,705,390 worldwide 613 citations · 49 works
- 9
Masami Nagahama
Japan · #2,730,965 worldwide 1.2k citations · 57 works
- 10
Hirotoshi Echizen
Japan · #2,900,974 worldwide 4k citations · 151 works
Which keywords describe research at Meiji Pharmaceutical University?
By fractional works in 2022-now, weighted toward what it does more of than the world: Oxidative Stress, Inflammation, Epidemiology, Medicinal Chemistry, Adverse Drug Reactions, Organic Synthesis, Antifungal Therapy and Pharmacokinetics.
- Pharmaceutical Industry
- Transition Metal Complexes
- Signal Detection
- Molecular Docking
- Metabolic Regulation
- Mitochondrial Dysfunction
- Drug Discovery
- Cell Signaling
- Immunocompromised Patients
- Apoptosis
- Antioxidants
- Fungal Pathogens
- Biomarkers
- Clinical Trials
- Pharmacokinetics
- Quality of Life
- Chemotherapy
- Adverse Drug Reactions
- Cancer
- Inflammation
- Epidemiology
- Oxidative Stress
- Medicinal Chemistry
- Antifungal Therapy
- Organic Synthesis
- Cancer Therapy
- Antioxidant
- Heterocycles
- Pharmacology
- Metabolism
- Enantioselective Synthesis
- Antibiotic Resistance
- Transition Metal Catalysis
- Candidiasis
- Invasive Fungal Infections
- Virulence Factors
- Staphylococcus aureus
- Pharmacovigilance
- Drug Target Identification
- Virtual Screening
Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology28▲ 2.0×52 topics
- Inflammation27▲ 3.6×53 topics
- Oxidative Stress25▲ 4.4×37 topics
- Cancer13▲ 2.8×28 topics
- Medicinal Chemistry12▲ 13×9 topics
- Adverse Drug Reactions12▲ 63×3 topics
- Antifungal Therapy11▲ 35×3 topics
- Chemotherapy11▲ 4.3×16 topics
- Organic Synthesis11▲ 26×5 topics
- Quality of Life10▲ 2.0×15 topics
- Cancer Therapy10▲ 5.0×13 topics
- Pharmacokinetics9▲ 9.7×6 topics
- Antioxidant9▲ 3.6×16 topics
- Clinical Trials8▲ 3.7×9 topics
- Heterocycles8▲ 27×5 topics
- Biomarkers8▲ 3.5×12 topics
- Pharmacology8▲ 9.6×9 topics
- Fungal Pathogens7▲ 16×5 topics
- Metabolism7▲ 4.0×17 topics
- Antioxidants7▲ 4.7×8 topics
- Enantioselective Synthesis7▲ 32×5 topics
- Apoptosis7▲ 6.2×13 topics
- Antibiotic Resistance7▲ 4.8×9 topics
- Immunocompromised Patients7▲ 34×2 topics
- Transition Metal Catalysis6▲ 22×3 topics
- Cell Signaling6▲ 11×10 topics
- Candidiasis6▲ 37×1 topic
- Drug Discovery6▲ 7.5×7 topics
- Invasive Fungal Infections6▲ 46×1 topic
- Mitochondrial Dysfunction6▲ 5.7×9 topics
- Virulence Factors6▲ 11×4 topics
- Metabolic Regulation5▲ 8.7×4 topics
- Staphylococcus aureus5▲ 19×2 topics
- Molecular Docking5▲ 11×3 topics
- Pharmacovigilance5▲ 79×1 topic
- Signal Detection5▲ 79×1 topic
- Drug Target Identification5▲ 15×1 topic
- Transition Metal Complexes5▲ 15×3 topics
- Virtual Screening5▲ 15×1 topic
- Pharmaceutical Industry4▲ 36×2 topics
Which research topics does Meiji Pharmaceutical University publish most on?
By volume in 2022-now: Antifungal resistance and susceptibility, Pharmacovigilance and Adverse Drug Reactions, Computational Drug Discovery Methods and Pharmacy and Medical Practices.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Antifungal resistance and susceptibility Infectious Diseases 6 works
- 2 Pharmacovigilance and Adverse Drug Reactions Toxicology 5 works
- 3 Computational Drug Discovery Methods Computational Theory and Mathematics 5 works
- 4 Pharmacy and Medical Practices Pharmacology 4 works
- 5 Pharmaceutical Economics and Policy Economics and Econometrics 4 works
- 6 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 4 works
- 7 Radical Photochemical Reactions Organic Chemistry 4 works
- 8 Pharmacogenetics and Drug Metabolism Pharmacology 3 works
- 9 Fungal Infections and Studies Epidemiology 3 works
- 10 Catalytic C–H Functionalization Methods Organic Chemistry 3 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Meiji Pharmaceutical University's research output changed?
Output in 2022-2025 was 4% higher than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Meiji Pharmaceutical University as a percentage of every work published that year, 0.0013% in 2024.
Fractional works of Meiji Pharmaceutical University over all fractional works that year. How the balance of science has shifted.
How much of it reaches the world top 10%
Year by year, against all institutions in the same year.
Of each year's output, the share that reached the world's 10% most cited for its field and year. Peak 9.8% in 2006.
Other research institutions in Tokyo
- The University of Tokyo
- Tokyo Institute of Technology
- Keio University
- Waseda University
- Tokyo University of Science
- Nihon University
- Hitachi (Japan)
- NTT (Japan)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Meiji Pharmaceutical University. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.
